Decision models for assessing the cost effectiveness of drug-eluting stents

Author： Kong David F   Eisenstein Eric L  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.6, 2005-06, pp. : 965-974

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controversy over cost effectiveness of drug-eluting stents

By  

Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Controversy over cost effectiveness of drug-eluting stents

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective

By Neyt Mattias  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 313-327

Adis International

Access to resources Recommend Favorite

Reimbursement decision for drotrecogin alfa, drug-eluting stents

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Drug-Eluting Stents

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 203-213

Karger

Access to resources Recommend Favorite